Saúde
Com nova e revolucionária tecnologia constantemente a desafiar o status quo, o setor da saúde está a evoluir. Mas num setor baseado em regulamentações, parcerias estratégicas são por vezes a chave para desenvolver negócios de forma bem sucedida. Os nossos assessores, apoiados por equipas sub-sectoriais globais, utilizam o seu conhecimento em M&A, growth equity e ECM, debt advisory e serviços de corporate finance, para encontrar a sua vantagem competitiva, gerir hábitos locais e ajudá-lo a criar a melhor estratégia.
Contactar acessor
Decopharma has been acquired by CTT
Decopharma has been acquired by CTT – Correios de Portugal, strengthening its position as a national reference in pharmaceutical logistics solutions. This strategic transaction marks an important step in the consolidation of the specialized logistics sector in Portugal, combining Decopharma’s expertise in healthcare logistics with CTT’s robust infrastructure and growth potential.
Saber maisLaboratório S. José foi adquirido pela SYNLAB
Os acionistas privados do Laboratório S. José venderam a empresa à SYNLAB.
Saber maisBanook, backed by Motion Equity, has acquired Fluidda
Banook Group has acquired Fluidda NV, marking a strategic expansion into advanced in-silico trials and respiratory disease modeling. Combining Banook’s expertise in cardiac safety and clinical data services with Fluidda’s AI-driven respiratory analytics creates a powerful, integrated platform. This deal strengthens Banook’s position in the contract research organization (CRO) sector, offering pharmaceutical clients broader, technology-enabled solutions to drive drug development and reduce costs.
Saber mais
Jan De Backer
CEO, Fluidda NV
Ler mais
Celebrity-backed rehab center joins UK’s expanding addiction treatment network
DEAL FLASH: The Providence Projects, one of the UK’s leading providers of affordable private alcohol and drug rehabilitation services, has been acquired by UKAT Group, a network of rehabilitation clinics across the UK.
Saber mais
Talk to our local advisor
Conheça os nossos especialistas setoriais globais
Michael Goldman
Oaklins TM Capital